Stock ABUS ARBUTUS BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Real-time Estimate Cboe BZX
Other stock markets
 02:50:46 2024-05-03 pm EDT 		5-day change 1st Jan Change
2.745 USD +2.43% Intraday chart for Arbutus Biopharma Corporation +0.18% +9.40%
May. 02 Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024
May. 02 Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arbutus Biopharma : Corporate Presentation - May 2024
PU
Arbutus: Q1 Earnings Snapshot
AQ
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GL
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
GL
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
GL
Arbutus Biopharma : Corporate Presentation - April 2024
PU
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
GL
Arbutus to Participate in Two Upcoming Investor Conferences
GL
Arbutus to Participate in Two Upcoming Investor Conferences
AQ
Arbutus Biopharma Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
AQ
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GL
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
AQ
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
GL
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
GL
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
AQ
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
GL
Arbutus to Present at Jefferies London Healthcare Conference
GL
Arbutus to Present at Jefferies London Healthcare Conference
AQ
Arbutus: Q3 Earnings Snapshot
AQ
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABUS Stock
  4. News Arbutus Biopharma Corporation
  5. Press Releases